Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14847 total
PGNY enters its November 6 earnings window with short sellers pulling back, borrow costs rising from low levels, and a fresh analyst initiation tilting the balance of Street opinion toward the bulls. Short interest has…
RVMD heads into its November 5 earnings date having shed nearly 5% over the past month, even as Wall Street has rarely been more aligned behind the daraxonrasib commercial story. The analyst picture is the most…
BNTX heads into its November 3 earnings date with a striking internal contradiction: its own chief executive has been selling shares every trading day for weeks, while options traders have swung to their most bullish…
10x Genomics is caught between a 425% year-to-date rally that has left analyst targets far behind and a 17% single-day fall that raises immediate questions about whether the re-rating has run its course. The stock…
Option Care Health closed Tuesday at $31.00, up 36% on the week. The move forced a wave of analyst downgrades on the same day, creating one of the starker disconnects in health care services this year: the stock…
Blackstone enters the final stretch before its October 16 earnings date with the stock finding a footing after last month's sharp sell-off, but options traders have not yet stood down. The price has stabilised. BX…
AFYA enters the final stretch before its October 20 earnings with a borrow market that has tightened dramatically in 48 hours, a fresh JPMorgan upgrade still on the tape, and a short score running near its highest…
BridgeBio Pharma heads into its October 30 earnings print with a well-entrenched short position, a shrinking activist register, and a Street that remains broadly constructive despite a 10% pullback over the past…
PSNL enters the final month before its next earnings print with a fresh analyst downgrade, an acquisition hanging over its head, and a stock that has given back 7% in a month. The headline this week is the BTIG move.…
UBER heads into its November 3 earnings date with the stock down 9% over the past month, yet the analyst community is becoming more constructive rather than less. The clearest story on the Street right now is a wall of…
TransMedics Group enters the week with an unusual split in its signals: fresh analyst optimism colliding with a stock down 11% over the past month and one of the highest short interest readings in the health care…
ALC heads into its November 11 earnings date down 8% over the past month, with the lending market relaxed and short sellers showing little conviction either way. The clearest feature of the current setup is how little…
Tradeweb Markets heads into its October 29 earnings report on the strongest weekly footing in months, up 6.9% on the week to $107.54, while the Street is quietly warming to a name that spent most of the summer under a…
LEVI has reported its Q3 results on schedule, the stock has bounced 4% on the week to $20.53, and yet the short position that spent all of September rebuilding has barely moved. The short interest story is the most…
AVTR heads into its October 28 earnings with a fresh analyst nudge, a broadly stable short book, and retail attention running at a two-standard-deviation high. The most notable development this week is on the Street.…
TTAN has bounced 8% on the week to $68.67, yet the stock remains 22% lower over the past month, and the data underneath the surface suggests short sellers are not giving up. Short interest has been grinding higher…
Dell Technologies enters October with a stock that has cleared the valuation gap the previous note flagged, leaving analysts scrambling to keep pace with a price that has moved faster than their models. The stock…
MRNA dropped 7.8% on Tuesday to $187.46, its sharpest single-day move in weeks, and the decline narrows but does not close the extraordinary gap between where the stock trades and where Wall Street says it belongs. The…
Twist Bioscience enters the week with a jarring disconnect: the stock fell nearly 19% on Tuesday even as analysts scrambled to raise price targets, and the trigger was an unmistakable wave of insider selling at the…
StoneCo is at the centre of one of the most charged situations in EM fintech this week, with a fresh activist filing, a 25% rally, and options positioning that has turned decisively bullish, all arriving at once. The…
